Literature DB >> 15469450

New V272A presenilin 1 mutation with very early onset subcortical dementia and parkinsonism.

A Jimenez-Escrig1, A Rabano, C Guerrero, J Simon, M S Barquero, I Güell, R C Ginestal, T Montero, L Orensanz.   

Abstract

In this report, we present the clinical and pathological details of a kindred of four individuals with a novel missense mutation (V272A) of the presenilin 1 gene (PSEN1) that experienced a subcortical dementia. The age of onset of symptoms ranged 26-36-year old, with an age at death of 36-46 years. Initial symptom was a marked mood disorder, with prominent parkinsonism in one case. The neuropsychological study, as well as the neuroimaging and PET in the proband were concordant with a subcortical dementia. The cerebral pathology showed in this patient, aside from the classical lesions of Alzheimer disease, Lewy bodies in cortex and substantia nigra, and widespread subcortical neuritic lesions. This clinical pattern and pathology expands the clinical spectrum of familial Alzheimer's disease and compel to include mutations of PSEN1 gene in the genetic study of subcortical dementia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469450     DOI: 10.1111/j.1468-1331.2004.00865.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  15 in total

1.  Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.

Authors:  Chenyou Sun; Xiaoming Ou; Jerry M Farley; Craig Stockmeier; Steven Bigler; Roberta Diaz Brinton; Jun Ming Wang
Journal:  Curr Alzheimer Res       Date:  2012-05       Impact factor: 3.498

Review 2.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

3.  Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutation.

Authors:  Steven P Cercy; Martin J Sadowski; Thomas Wisniewski
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

4.  Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation.

Authors:  Miryam Carecchio; Marina Picillo; Lorella Valletta; Antonio E Elia; Tobias B Haack; Autilia Cozzolino; Annalisa Vitale; Barbara Garavaglia; Arcangela Iuso; Caterina F Bagella; Sabina Pappatà; Paolo Barone; Holger Prokisch; Luigi Romito; Valeria Tiranti
Journal:  Neurogenetics       Date:  2017-06-29       Impact factor: 2.660

5.  Studies of protein aggregation in A53T α-synuclein transgenic, Tg2576 transgenic, and P246L presenilin-1 knock-in cross bred mice.

Authors:  Kristel L Emmer; Jason P Covy; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2011-12-13       Impact factor: 3.046

6.  A heterozygous de novo PSEN1 mutation in a patient with early-onset parkinsonism.

Authors:  Yueting Chen; Peng Liu; Fei Xie; Bo Wang; Zhiru Lin; Wei Luo
Journal:  Neurol Sci       Date:  2021-11-29       Impact factor: 3.307

Review 7.  Alzheimer disease pathology as a host response.

Authors:  Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

Review 8.  Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta.

Authors:  Rudy J Castellani; Hyoung-gon Lee; Sandra L Siedlak; Akihiko Nunomura; Takaaki Hayashi; Masao Nakamura; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 9.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

10.  Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP.

Authors:  Rita Joao Guerreiro; Miquel Baquero; Rafael Blesa; Mercè Boada; Jose Miguel Brás; Maria J Bullido; Ana Calado; Richard Crook; Carla Ferreira; Ana Frank; Teresa Gómez-Isla; Isabel Hernández; Alberto Lleó; Alvaro Machado; Pablo Martínez-Lage; José Masdeu; Laura Molina-Porcel; José L Molinuevo; Pau Pastor; Jordi Pérez-Tur; Rute Relvas; Catarina Resende Oliveira; Maria Helena Ribeiro; Ekaterina Rogaeva; Alfredo Sa; Lluís Samaranch; Raquel Sánchez-Valle; Isabel Santana; Lluís Tàrraga; Fernando Valdivieso; Andrew Singleton; John Hardy; Jordi Clarimón
Journal:  Neurobiol Aging       Date:  2008-07-30       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.